Molecular targets for antifungals in amino acid and protein biosynthetic pathways

Amino Acids. 2021 Jul;53(7):961-991. doi: 10.1007/s00726-021-03007-6. Epub 2021 Jun 3.

Abstract

Fungi cause death of over 1.5 million people every year, while cutaneous mycoses are among the most common infections in the world. Mycoses vary greatly in severity, there are long-term skin (ringworm), nail or hair infections (tinea capitis), recurrent like vaginal candidiasis or severe, life-threatening systemic, multiorgan infections. In the last few years, increasing importance is attached to the health and economic problems caused by fungal pathogens. There is a growing need for improvement of the availability of antifungal drugs, decreasing their prices and reducing side effects. Searching for novel approaches in this respect, amino acid and protein biosynthesis pathways appear to be competitive. The route that leads from amino acid biosynthesis to protein folding and its activation is rich in enzymes that are descriptive of fungi. Blocking the action of those enzymes often leads to avirulence or growth inhibition. In this review, we want to trace the principal processes of fungi vitality. We present the data of genes encoding enzymes involved in amino acid and protein biosynthesis, potential molecular targets in antifungal chemotherapy, and describe the impact of inhibitors on fungal organisms.

Keywords: Amino acid biosynthesis; Antifungal targets; Aspergillus; Candida; Plant pathogens; Protein biosynthesis.

Publication types

  • Review

MeSH terms

  • Amino Acids / biosynthesis*
  • Antifungal Agents / pharmacology*
  • Biosynthetic Pathways / drug effects*
  • Fungi / drug effects*
  • Fungi / metabolism
  • Humans
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Protein Biosynthesis*

Substances

  • Amino Acids
  • Antifungal Agents